Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy

Komaki H, Maegaki Y, Matsumura T, et al. Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy. Annals of clinical and translational neurology 2020;7:181-190   Abstract OBJECTIVE: Duchenne muscular dystrophy (DMD) is a progressive muscular disease characterized by chronic cycles of inflammatory and necrotic processes. Prostaglandin D2 (PGD2 ) is produced by […]